Cargando…
Impact of neurocognitive deficits on patient–proxy agreement regarding health-related quality of life in low-grade glioma patients
PURPOSE: Clinical trials in glioma patients with neurocognitive deficits face challenges due to lacking or unreliable patient self-reports on their health-related quality of life (HRQOL). Patient–proxy data could help solve this issue. We determined whether patient–proxy concordance levels were affe...
Autores principales: | Ediebah, Divine E., Reijneveld, Jaap C., Taphoorn, Martin J. B., Coens, Corneel, Zikos, Efstathios, Aaronson, Neil K., Heimans, Jan J., Bottomley, Andrew, Klein, Martin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer International Publishing
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5334398/ https://www.ncbi.nlm.nih.gov/pubmed/27744512 http://dx.doi.org/10.1007/s11136-016-1426-z |
Ejemplares similares
-
Neurocognitive impairment and patient–proxy agreement on health-related quality of life evaluations in recurrent high-grade glioma patients
por: Caramanna, Ivan, et al.
Publicado: (2022) -
Health-related quality of life in high-grade glioma patients
por: Dirven, Linda, et al.
Publicado: (2014) -
Do neurocognitive impairments explain the differences between brain tumor patients and their proxies when assessing the patient’s IADL?
por: Oort, Quirien, et al.
Publicado: (2022) -
Antiepileptic drug treatment in the end-of-life phase of glioma patients: a feasibility study
por: Koekkoek, Johan A. F., et al.
Publicado: (2015) -
Establishing anchor-based minimally important differences for the EORTC QLQ-C30 in glioma patients
por: Dirven, Linda, et al.
Publicado: (2021)